v3.25.1
Balance Sheet Details (Tables)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Balance Sheet Details [Abstract]    
Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:

 

   March 31,
2025		   December 31,
2024		 
Prepaid insurance costs  $95,012   $17,198 
Other prepaid expenses & current assets   128,258    49,501 
Total prepaid expenses & current assets  $223,270   $66,699 

Prepaid expenses and other current assets consisted of the following:

 

   December 31,
2024		   December 31,
2023		 
Prepaid insurance costs  $  17,198   $  55,215 
Other prepaid expenses & current assets   49,501    29,476 
Total prepaid expenses & current assets  $66,699   $84,691 
Schedule of Property and Equipment, Net  

Property and equipment, net consisted of the following:

 

   December 31,
2024		   December 31,
2023		 
Lab equipment  $151,134   $131,963 
Total property and equipment, gross   151,134    131,963 
Accumulated depreciation   (94,802)   (66,879)
Total property and equipment, net  $56,332   $65,084 
Schedule of Accrued Expenses

Accrued expenses consisted of the following:

 

   March 31,
2025		   December 31,
2024		 
Accrued payroll and related expenses  $217,967   $835,724 
Accrued clinical study expenses   236,168    183,824 
Accrued professional fees   
—
    67,049 
Accrued clinical development costs   
—
    41,203 
Accrued other expenses   9,497    
—
 
Total accrued expenses  $463,632   $1,127,800 

Accrued expenses consisted of the following:

 

   December 31,
2024		   December 31,
2023		 
Accrued payroll and related expenses  $835,724   $768,720 
Accrued clinical study expenses   183,824    10,268 
Accrued professional fees   67,049    219,888 
Accrued clinical development costs   41,203    153,584 
Total accrued expenses  $1,127,800   $1,152,460